Back to top

LACOG 0421 – Action HIV

  /    /  LACOG 0421 – Action HIV

ACTION HIV (Anal Cancer TherapIes and Outcomes initiative for patients living with and without HIV): A global record of patients with anal squamous cell carcinoma with and without HIV infection.

Type of Study: Epidemiological

Sponsor / Support: LACOG

Primary Objectives: Describe the epidemiological characteristics and prognostic factors for disease-free survival of patients with CC with and without HIV infection.

Design: Epidemiological study of the retrospective, multicenter, multinational cohort, with data collection from medical records.

Sample Size: 300 patients

Principal Investigator: Rachel Riechelmann

Countries LATAM: Brazil Identifier: NCT05328765